|
2022-08-22 |
2022-08-19 |
B
Purchase
|
Bailey Gregory
Non-Executive Director
|
38,000
+1.5%
148.04
5,625,676
USD
|
38,000
+1.5%
|
148.04
|
5,625,676
USD
|
|
|
2022-05-12 |
2022-05-10 |
PS
Planned sale
|
Clark George C.
VP, Chief Accounting Officer
Officer
|
4,200
-50.8%
141.50
594,300
USD
|
4,200
-50.8%
|
141.50
|
594,300
USD
|
|
|
2022-01-24 |
2022-01-19 |
PS
Planned sale
|
Clark George C.
VP, Chief Accounting Officer
Officer
|
3,520
-36.9%
119.37
420,180
USD
|
3,520
-36.9%
|
119.37
|
420,180
USD
|
|
|
2022-01-24 |
2022-01-19 |
PS
Planned sale
|
Clark George C.
VP, Chief Accounting Officer
Officer
|
500
-5.0%
118.05
59,024
USD
|
500
-5.0%
|
118.05
|
59,024
USD
|
|
|
2022-01-24 |
2022-01-19 |
PS
Planned sale
|
Clark George C.
VP, Chief Accounting Officer
Officer
|
2,159
-17.7%
116.02
250,485
USD
|
2,159
-17.7%
|
116.02
|
250,485
USD
|
|
|
2022-01-24 |
2022-01-19 |
PS
Planned sale
|
Clark George C.
VP, Chief Accounting Officer
Officer
|
3,196
-20.8%
114.93
367,314
USD
|
3,196
-20.8%
|
114.93
|
367,314
USD
|
|
|
2021-12-22 |
2021-12-20 |
PS
Planned sale
|
GREGORY JULIA P
Non-Executive Director
|
12,000
-100.0%
125.00
1,500,000
USD
|
12,000
-100.0%
|
125.00
|
1,500,000
USD
|
|
|
2021-12-22 |
2021-12-20 |
PS
Planned sale
|
Clark George C.
VP, Chief Accounting Officer
Officer
|
1,915
-18.9%
123.84
237,154
USD
|
1,915
-18.9%
|
123.84
|
237,154
USD
|
|
|
2021-12-16 |
2021-12-15 |
PS
Planned sale
|
Stock Elyse
Chief Medical Officer
Officer
|
1,589
-17.5%
106.17
168,701
USD
|
1,589
-17.5%
|
106.17
|
168,701
USD
|
|
|
2021-12-16 |
2021-12-15 |
PS
Planned sale
|
Stock Elyse
Chief Medical Officer
Officer
|
20,330
-69.2%
105.43
2,143,426
USD
|
20,330
-69.2%
|
105.43
|
2,143,426
USD
|
|
|
2021-12-16 |
2021-12-14 |
PS
Planned sale
|
Stock Elyse
Chief Medical Officer
Officer
|
6,939
-48.2%
105.02
728,762
USD
|
6,939
-48.2%
|
105.02
|
728,762
USD
|
|
|
2021-12-10 |
2021-12-10 |
PS
Planned sale
|
Engelhart James
Chief Financial Officer
Officer
|
1,382
-11.0%
103.85
143,516
USD
|
1,382
-11.0%
|
103.85
|
143,516
USD
|
|
|
2021-12-10 |
2021-12-10 |
PS
Planned sale
|
Engelhart James
Chief Financial Officer
Officer
|
23,487
-65.1%
102.70
2,412,162
USD
|
23,487
-65.1%
|
102.70
|
2,412,162
USD
|
|
|
2021-12-10 |
2021-12-10 |
PS
Planned sale
|
Engelhart James
Chief Financial Officer
Officer
|
10,131
-21.9%
102.01
1,033,467
USD
|
10,131
-21.9%
|
102.01
|
1,033,467
USD
|
|
|
2021-12-01 |
2021-11-29 |
S
Sale
|
Doogan Declan
Non-Executive Director
|
11,499
-1.3%
113.25
1,302,316
USD
|
11,499
-1.3%
|
113.25
|
1,302,316
USD
|
|
|
2021-12-01 |
2021-11-29 |
S
Sale
|
Doogan Declan
Non-Executive Director
|
13,026
-1.5%
112.40
1,464,117
USD
|
13,026
-1.5%
|
112.40
|
1,464,117
USD
|
|
|
2021-11-17 |
2021-11-16 |
S
Sale
|
Doogan Declan
Non-Executive Director
|
7,073
-0.8%
117.87
833,711
USD
|
7,073
-0.8%
|
117.87
|
833,711
USD
|
|
|
2021-11-17 |
2021-11-16 |
S
Sale
|
Doogan Declan
Non-Executive Director
|
18,230
-2.0%
116.69
2,127,173
USD
|
18,230
-2.0%
|
116.69
|
2,127,173
USD
|
|
|
2021-11-17 |
2021-11-16 |
S
Sale
|
Doogan Declan
Non-Executive Director
|
12,437
-1.3%
115.90
1,441,501
USD
|
12,437
-1.3%
|
115.90
|
1,441,501
USD
|
|
|
2021-11-10 |
2021-11-10 |
B
Purchase
|
CHILDS JOHN W
Non-Executive Director
|
1,110
+0.0%
123.30
136,862
USD
|
1,110
+0.0%
|
123.30
|
136,862
USD
|
|
|
2021-11-10 |
2021-11-10 |
B
Purchase
|
CHILDS JOHN W
Non-Executive Director
|
3,890
+0.2%
122.75
477,480
USD
|
3,890
+0.2%
|
122.75
|
477,480
USD
|
|
|
2021-03-17 |
2021-03-17 |
B
Purchase
|
CHILDS JOHN W
Non-Executive Director
|
13,157
+0.5%
76.00
999,932
USD
|
13,157
+0.5%
|
76.00
|
999,932
USD
|
|
|
2021-03-03 |
2021-03-02 |
B
Purchase
|
CHILDS JOHN W
Non-Executive Director
|
10,000
+0.4%
85.14
851,370
USD
|
10,000
+0.4%
|
85.14
|
851,370
USD
|
|
|
2020-11-23 |
2020-11-23 |
B
Purchase
|
CHILDS JOHN W
Non-Executive Director
|
5,000
+0.2%
89.55
447,737
USD
|
5,000
+0.2%
|
89.55
|
447,737
USD
|
|
|
2020-11-04 |
2020-11-02 |
PS
Planned sale
|
JONES WILLIAM A JR
CCO-Migraine & Common Disease
Officer
|
1,300
-42.6%
77.70
101,005
USD
|
1,300
-42.6%
|
77.70
|
101,005
USD
|
|
|
2020-11-04 |
2020-11-02 |
PS
Planned sale
|
JONES WILLIAM A JR
CCO-Migraine & Common Disease
Officer
|
4,010
-56.8%
77.01
308,799
USD
|
4,010
-56.8%
|
77.01
|
308,799
USD
|
|
|
2020-11-04 |
2020-11-02 |
PS
Planned sale
|
JONES WILLIAM A JR
CCO-Migraine & Common Disease
Officer
|
24,690
-77.8%
76.02
1,876,872
USD
|
24,690
-77.8%
|
76.02
|
1,876,872
USD
|
|
|
2020-10-23 |
2020-10-23 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
212
-0.0%
79.94
16,948
USD
|
212
-0.0%
|
79.94
|
16,948
USD
|
|
|
2020-10-23 |
2020-10-23 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
10,191
-0.4%
78.89
803,918
USD
|
10,191
-0.4%
|
78.89
|
803,918
USD
|
|
|
2020-10-23 |
2020-10-22 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
3,100
-0.1%
79.88
247,632
USD
|
3,100
-0.1%
|
79.88
|
247,632
USD
|
|
|
2020-10-23 |
2020-10-22 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
21,466
-0.8%
79.41
1,704,720
USD
|
21,466
-0.8%
|
79.41
|
1,704,720
USD
|
|
|
2020-10-21 |
2020-10-19 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
4,554
-0.2%
78.98
359,655
USD
|
4,554
-0.2%
|
78.98
|
359,655
USD
|
|
|
2020-10-21 |
2020-10-16 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
3,748
-0.1%
78.88
295,638
USD
|
3,748
-0.1%
|
78.88
|
295,638
USD
|
|
|
2020-10-14 |
2020-10-12 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
6,729
-0.3%
78.87
530,740
USD
|
6,729
-0.3%
|
78.87
|
530,740
USD
|
|
|
2020-10-09 |
2020-10-08 |
PS
Planned sale
|
Gentile Kimberly
SVP, Clinical Operations
Officer
|
2,458
-40.3%
77.42
190,300
USD
|
2,458
-40.3%
|
77.42
|
190,300
USD
|
|
|
2020-10-09 |
2020-10-08 |
PS
Planned sale
|
Gentile Kimberly
SVP, Clinical Operations
Officer
|
15,781
-72.1%
76.42
1,205,938
USD
|
15,781
-72.1%
|
76.42
|
1,205,938
USD
|
|
|
2020-10-09 |
2020-10-08 |
PS
Planned sale
|
Gentile Kimberly
SVP, Clinical Operations
Officer
|
5,261
-19.4%
75.62
397,844
USD
|
5,261
-19.4%
|
75.62
|
397,844
USD
|
|
|
2020-09-22 |
2020-09-21 |
B
Purchase
|
CHILDS JOHN W
Non-Executive Director
|
3,322
+0.1%
59.25
196,829
USD
|
3,322
+0.1%
|
59.25
|
196,829
USD
|
|
|
2020-09-14 |
2020-09-11 |
B
Purchase
|
CHILDS JOHN W
Non-Executive Director
|
6,678
+0.3%
59.00
393,984
USD
|
6,678
+0.3%
|
59.00
|
393,984
USD
|
|
|
2020-08-12 |
2020-08-11 |
B
Purchase
|
CHILDS JOHN W
Non-Executive Director
|
15,129
+0.6%
61.87
936,093
USD
|
15,129
+0.6%
|
61.87
|
936,093
USD
|
|
|
2020-08-12 |
2020-08-11 |
B
Purchase
|
CHILDS JOHN W
Non-Executive Director
|
7,271
+0.3%
61.28
445,568
USD
|
7,271
+0.3%
|
61.28
|
445,568
USD
|
|
|
2020-08-12 |
2020-08-11 |
B
Purchase
|
CHILDS JOHN W
Non-Executive Director
|
2,600
+0.1%
60.32
156,824
USD
|
2,600
+0.1%
|
60.32
|
156,824
USD
|
|
|
2020-07-10 |
2020-07-08 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
5,991
-0.2%
75.93
454,888
USD
|
5,991
-0.2%
|
75.93
|
454,888
USD
|
|
|
2020-07-10 |
2020-07-08 |
PS
Planned sale
|
Berman Robert
Special Projects & Med Ovrsght
Officer
|
2,778
-89.1%
75.29
209,145
USD
|
2,778
-89.1%
|
75.29
|
209,145
USD
|
|
|
2020-07-10 |
2020-07-08 |
PS
Planned sale
|
Berman Robert
Special Projects & Med Ovrsght
Officer
|
55,626
-94.7%
75.25
4,185,745
USD
|
55,626
-94.7%
|
75.25
|
4,185,745
USD
|
|
|
2020-07-10 |
2020-07-08 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
44,009
-1.7%
75.12
3,305,877
USD
|
44,009
-1.7%
|
75.12
|
3,305,877
USD
|
|
|
2020-06-25 |
2020-06-24 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
2,395
-0.1%
70.24
168,225
USD
|
2,395
-0.1%
|
70.24
|
168,225
USD
|
|
|
2020-06-25 |
2020-06-24 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
1,600
-0.1%
69.29
110,865
USD
|
1,600
-0.1%
|
69.29
|
110,865
USD
|
|
|
2020-06-25 |
2020-06-23 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
835
-0.0%
75.18
62,779
USD
|
835
-0.0%
|
75.18
|
62,779
USD
|
|
|
2020-06-25 |
2020-06-23 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
63,257
-2.3%
74.60
4,719,257
USD
|
63,257
-2.3%
|
74.60
|
4,719,257
USD
|
|
|
2020-06-25 |
2020-06-23 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
24,084
-0.9%
73.72
1,775,369
USD
|
24,084
-0.9%
|
73.72
|
1,775,369
USD
|
|
|
2020-06-25 |
2020-06-23 |
PS
Planned sale
|
Berman Robert
Special Projects & Med Ovrsght
Officer
|
4,296
-92.6%
75.05
322,431
USD
|
4,296
-92.6%
|
75.05
|
322,431
USD
|
|
|
2020-06-25 |
2020-06-23 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
13,467
-0.5%
72.70
979,027
USD
|
13,467
-0.5%
|
72.70
|
979,027
USD
|
|
|
2020-06-22 |
2020-06-22 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
49,132
-1.8%
73.64
3,618,012
USD
|
49,132
-1.8%
|
73.64
|
3,618,012
USD
|
|
|
2020-06-22 |
2020-06-22 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
20,659
-0.7%
72.91
1,506,202
USD
|
20,659
-0.7%
|
72.91
|
1,506,202
USD
|
|
|
2020-06-22 |
2020-06-22 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
10,540
-0.4%
72.01
758,961
USD
|
10,540
-0.4%
|
72.01
|
758,961
USD
|
|
|
2020-06-22 |
2020-06-19 |
PS
Planned sale
|
Berman Robert
Special Projects & Med Ovrsght
Officer
|
986
-74.3%
75.07
74,016
USD
|
986
-74.3%
|
75.07
|
74,016
USD
|
|
|
2020-06-22 |
2020-06-19 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
428
-0.0%
75.22
32,193
USD
|
428
-0.0%
|
75.22
|
32,193
USD
|
|
|
2020-06-22 |
2020-06-19 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
22,584
-0.8%
73.78
1,666,268
USD
|
22,584
-0.8%
|
73.78
|
1,666,268
USD
|
|
|
2020-06-22 |
2020-06-19 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
12,157
-0.4%
72.93
886,619
USD
|
12,157
-0.4%
|
72.93
|
886,619
USD
|
|
|
2020-06-22 |
2020-06-19 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
21,798
-0.8%
71.98
1,568,935
USD
|
21,798
-0.8%
|
71.98
|
1,568,935
USD
|
|
|
2020-06-22 |
2020-06-19 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
58,238
-2.0%
70.91
4,129,855
USD
|
58,238
-2.0%
|
70.91
|
4,129,855
USD
|
|
|
2020-06-22 |
2020-06-19 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
26,814
-0.9%
70.10
1,879,793
USD
|
26,814
-0.9%
|
70.10
|
1,879,793
USD
|
|
|
2020-06-22 |
2020-06-19 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
22,012
-0.7%
69.01
1,519,094
USD
|
22,012
-0.7%
|
69.01
|
1,519,094
USD
|
|
|
2020-06-22 |
2020-06-18 |
PS
Planned sale
|
Berman Robert
Special Projects & Med Ovrsght
Officer
|
1,400
-80.4%
76.05
106,467
USD
|
1,400
-80.4%
|
76.05
|
106,467
USD
|
|
|
2020-06-22 |
2020-06-18 |
PS
Planned sale
|
Berman Robert
Special Projects & Med Ovrsght
Officer
|
59,914
-97.2%
75.25
4,508,822
USD
|
59,914
-97.2%
|
75.25
|
4,508,822
USD
|
|
|
2020-06-18 |
2020-06-17 |
PS
Planned sale
|
Gentile Kimberly
SVP, Clinical Operations
Officer
|
400
-9.9%
70.20
28,081
USD
|
400
-9.9%
|
70.20
|
28,081
USD
|
|
|
2020-06-17 |
2020-06-17 |
PS
Planned sale
|
Gentile Kimberly
SVP, Clinical Operations
Officer
|
24,000
-86.8%
70.20
1,684,870
USD
|
24,000
-86.8%
|
70.20
|
1,684,870
USD
|
|
|
2020-06-17 |
2020-06-16 |
PS
Planned sale
|
Doogan Declan
Non-Executive Director
|
300
-0.0%
69.42
20,825
USD
|
300
-0.0%
|
69.42
|
20,825
USD
|
|
|
2020-06-17 |
2020-06-16 |
PS
Planned sale
|
Doogan Declan
Non-Executive Director
|
25,208
-3.9%
68.73
1,732,458
USD
|
25,208
-3.9%
|
68.73
|
1,732,458
USD
|
|
|
2020-06-17 |
2020-06-16 |
PS
Planned sale
|
Doogan Declan
Non-Executive Director
|
31,920
-4.7%
67.90
2,167,515
USD
|
31,920
-4.7%
|
67.90
|
2,167,515
USD
|
|
|
2020-06-17 |
2020-06-16 |
PS
Planned sale
|
Doogan Declan
Non-Executive Director
|
2,572
-0.4%
66.94
172,162
USD
|
2,572
-0.4%
|
66.94
|
172,162
USD
|
|
|
2020-06-17 |
2020-06-15 |
PS
Planned sale
|
Doogan Declan
Non-Executive Director
|
15,797
-2.3%
68.10
1,075,801
USD
|
15,797
-2.3%
|
68.10
|
1,075,801
USD
|
|
|
2020-06-17 |
2020-06-15 |
PS
Planned sale
|
Doogan Declan
Non-Executive Director
|
18,703
-2.6%
67.51
1,262,557
USD
|
18,703
-2.6%
|
67.51
|
1,262,557
USD
|
|
|
2020-06-17 |
2020-06-15 |
PS
Planned sale
|
Doogan Declan
Non-Executive Director
|
34,336
-4.5%
66.05
2,267,872
USD
|
34,336
-4.5%
|
66.05
|
2,267,872
USD
|
|
